SKIN Stock Overview
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide.
The Beauty Health Company Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$10.75|
|52 Week High||US$26.90|
|52 Week Low||US$8.27|
|1 Month Change||-5.95%|
|3 Month Change||-5.54%|
|1 Year Change||-56.28%|
|3 Year Change||n/a|
|5 Year Change||n/a|
|Change since IPO||-0.83%|
Recent News & Updates
|SKIN||US Personal Products||US Market|
Return vs Industry: SKIN underperformed the US Personal Products industry which returned -38.1% over the past year.
Return vs Market: SKIN underperformed the US Market which returned -18.9% over the past year.
|SKIN Average Weekly Movement||11.8%|
|Personal Products Industry Average Movement||10.8%|
|Market Average Movement||7.4%|
|10% most volatile stocks in US Market||15.5%|
|10% least volatile stocks in US Market||3.3%|
Stable Share Price: SKIN is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 12% a week.
Volatility Over Time: SKIN's weekly volatility (12%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
The Beauty Health Company designs, develops, manufactures, markets, and sells aesthetic technologies and products worldwide. The company’s flagship product includes HydraFacial that enhance the skin to cleanse, peel, exfoliate, extract, infuse, and hydrate the skin with proprietary solutions and serums. Its products also comprise Syndeo, a HydraFacial Delivery System designed to elevate every part of the treatment and connects providers to the consumer’s preferences to create a more personalized experience; HydraFacial Nation App, an app that allows consumers to learn about their skin health, discover treatment options, and track their treatments over time; and Keravive, a treatment for scalp health.
The Beauty Health Company Fundamentals Summary
|SKIN fundamental statistics|
Is SKIN overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SKIN income statement (TTM)|
|Cost of Revenue||US$103.71m|
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
|Earnings per share (EPS)||0.16|
|Net Profit Margin||6.73%|
How did SKIN perform over the long term?See historical performance and comparison